We previously demonstrated that skeletal mass, structure and biomechanical properties vary considerably in heterogeneous stock (HS) rat strains. In addition, we observed strong heritability for several of these skeletal phenotypes in the HS rat model, suggesting that it represents a unique genetic resource for dissecting the complex genetics underlying bone fragility. The purpose of this study was to identify and localize genes associated with bone mineral density in HS rats. We measured bone phenotypes from 1524 adult male and female HS rats between 17 to 20 weeks of age. Phenotypes included DXA measurements for bone mineral content and areal bone mineral density for femur and lumbar spine (L3-5), and volumetric BMD measurements by CT for the midshaft and distal femur, femur neck and 5 th lumbar vertebra. A total of 70,000 polymorphic SNPs distributed throughout the genome were selected from genotypes obtained from the Affymetrix rat custom SNPs array for the HS rat population. These SNPs spanned the HS rat genome with a mean linkage disequilibrium coefficient between neighboring SNPs of 0.95. Haplotypes were estimated across the entire genome for each rat using a multipoint haplotype reconstruction method, which calculates the probability of descent for each genotyped locus from each of the 8 founder HS strains. The haplotypes were tested for association with each bone density phenotype via a mixed model with covariate adjustment. We identified quantitative trait
Introduction
Osteoporosis is a common bone disease leading to increased susceptibility to fracture at multiple skeletal sites 1 resulting in a substantial public health burden. Bone mineral density (BMD), structure and strength are the major determinants for skeletal fracture. [2] [3] [4] Several studies demonstrated that these phenotypes are highly heritable. [5] [6] [7] [8] As much as 80% of the variability of BMD is due to heritable factors. 7 Identification of genes underlying BMD phenotypes, particularly at the most common skeletal fracture sites, will provide valuable insights for understanding the genetics of osteoporosis and fracture risk.
Previously, using 4 inbred rats (F344, LEW, COP and DA), we identified several chromosomal regions linked to bone density, structure and strength phenotypes. [9] [10] [11] [12] [13] Although, these inbred rat models have served an important role in genetic mapping for bone fragility phenotypes, most of these QTLs encompass 20 to 30 cM and harbor hundreds of potential candidate genes. Subsequently, using genomic expression analysis, we identified several potential candidate genes within some of these QTLs. [14] [15] [16] However, it is a formidable challenge to narrow these critical QTL regions to a small chromosomal segment containing a few genes. Several alternative approaches such as the development of recombinant inbred and congenic lines have been attempted, but these approaches have proven to be time-consuming and labor intensive and often do not have enough resolution to detect the causal genes and variants, especially those of relatively small effect.
The heterogeneous stock (HS) rat, a unique rat model, was developed by the National Institutes of Health (NIH) in 1984. 17 These rats were originally derived from eight inbred founder strains: Agouti (ACI/N), Brown Norway (BN/SsN), Buffalo (BUF/N), Fischer 344 (F344/N), M520/N, Maudsley Reactive (MR/N), Wistar-Kyoto (WKY/N) and Wistar-Nettleship (WN/N). 17 Subsequently, this stock was bred for 50 generations using a rotational outbreeding regime to minimize the extent of inbreeding, drift and fixation. 18 Importantly, each of these HS rats represents a unique, genetically random mosaic of founding animal chromosomes due to recombination that have accumulated over many generations. It has been estimated that the average distance between recombination events in these rats is approximately 2 cM. 19 Thus, the HS rat is a unique genetic resource for the fine mapping of QTLs to very small genomic regions. Recently, these rats have been successfully used to fine-map QTLs for diabetes 20 and fear-related behavior phenotypes. 21 In a previous study, we demonstrated that skeletal mass, structure and biomechanical properties vary considerably in heterogeneous stock (HS) rat strains. 22 In addition, we observed strong heritability for several of these skeletal phenotypes, suggesting that the HS rat represents a unique genetic resource for dissecting the complex genetics underlying bone fragility. In a recent study, genomic sequence data was obtained on animals from each of the HS founder strains, along with genotypes for a dense SNP marker map in a large number of HS offspring. Phenotypic data for over 150 physiological and other phenotypes, including measures of bone density, were also obtained on the HS offspring, and over 1,000 genomic regions demonstrated association with one or more of the phenotypes measured. 23 The sequence data from the founder strains were then used to identify single genomic variants that fully accounted for an observed association in one of these regions, using a novel method that exploits the HS pedigree structure. 23 Numerous such variants were identified for phenotypes measured in the HS offspring; however, no single genetic variants explaining associations with bone phenotypes were detected, consistent with the complex genetic architecture of bone density observed previously both in humans and animal models. 23 The purpose of this study is to address this genetic complexity by use of dense SNP genotype data to perform high-resolution mapping for bone mineral density (BMD) phenotypes in HS rat offspring. We hypothesize that we will detect and localize QTLs for several key BMD phenotypes at the most common skeletal fracture sites. We expect that the QTLs detected via the HS approach will comprise much smaller genomic regions than bone density QTLs detected by us and others using inbred rat crosses. In the future, these results may allow more detailed study of the smaller number of genes in the regions detected compared to prior approaches, and contribute to better understanding of the complex genetic architecture of the BMD phenotypes in HS rats.
Materials and Methods

Animals
We used 1524 HS rats (male n=728; female n=796) in this study. The HS rats were bred and grown at the Autonomous University of Barcelona. Microchips were implanted in these rats for identification and multiple physiology and behavior phenotypes were obtained at several time points. The rats were housed in cages in pairs (males) and trios (females) and maintained with food and water available ad libitum, under conditions of controlled temperature (22 + 2 °C), 50-70% relative humidity and a 12-h light-dark cycle (lights on at 0800 h). The HS rats were raised over 2.5 years in batches of approximately 250 animals in accordance with the Spanish legislation on "Protection of Animals used for Experimental and Other Scientific Purposes" and the European Communities Council Directive (86/609/ EEC).
Euthanasia and specimen collection
HS rats were euthanized between 17 and 20 weeks of age by ether inhalation. The lower limbs and lumbar vertebrae (L3-5) were dissected from these animals. The lower limbs on the right side were immediately stored at −20°C for subsequent biomechanical testing. The lower limbs on the left side were stripped of muscle, transferred to 70% ethyl alcohol and stored at 4°C for densitometry analyses.
Dual energy X-ray absorptiometry (DXA)
The left femur and lumbar vertebrae 3-5 (L3-5) of the HS rats were scanned using DXA (PIXImus II mouse densitometer; Lunar Corp., Madison, WI, USA) with ultra-high resolution (0.18 × 0.18 mm/pixel). During scanning dissected bones were positioned on a platform supplied by the manufacturer. After completion of the scan of each bone, mutually exclusive region of interest (ROI) boxes were drawn around the bone from which aBMD (g/cm 2 ) and BMC (g) measurements were obtained.
Peripheral quantitative computed tomography (pQCT)
The left femurs were placed in plastic tubes filled with 70% ethyl alcohol and centered in the gantry of a Norland Stratec XCT Research SA+pQCT (Stratec Electronics, Pforzheim, Germany). Single slice measurements of 0.26 mm thickness and a voxel size of 0.07 mm were taken for the femur. Two femoral cross-sectional slices were obtained for each femur: one slice through femoral midshaft and one slice approximately 1 mm below the growth plate of distal femur. The slice through the femur midshaft included only cortical bone, whereas the distal slice included the cortical shell and secondary spongiosa. L5 vertebrae were scanned in cross-section at the caudo-cranial center of the vertebral body. For femoral neck, five consecutive scans perpendicular to the neck axis were obtained 0.25 mm apart from each other starting at the base of the femoral head and ending at the greater trochanter. For each slice, the X-ray source was rotated through 180° of projection. Density thresholds of 500 and 900 were used to identify trabecular and compact bone. Volumetric density (vBMD; mg/cm 3 ) of cortical and trabecular bone were measured from each slice separately at distal femur and L5 spine. vBMD for femoral neck was measured from the average values of all five slices. In addition, total cross-sectional area at femur midshaft and L5 spine were measured to enable the determination of whether BMD QTLs detected were due primarily to bone size effects.
Genotyping
DNA was extracted from liver tissues from 8 original founders and 1524 HS rats using standard protocols. Genotypes for over 900,000 SNPs for each rat were obtained from an Affymetrix rat custom SNP array (www.affymetrix.com). SNPs were algorithmically selected taking into account the strain distribution pattern to maximize the information available for mapping as well as the SNP call quality metrics. The set of SNPs were pruned to approximately 70,000 high quality SNPs which covered the HS rat genome with a mean linkage disequilibrium coefficient between neighboring SNPs of 0.95.
Statistical genetic analysis
Haplotypes were constructed for each rat across the genome using the multipoint haplotype reconstruction method HAPPY (http://www.well.ox.ac.uk/happy). 19 HAPPY uses a hidden Markov model to calculate the probability of descent from each founder at each genotyped locus. A mixed model approach was then employed to test for association between each haplotype and the bone phenotype of interest. The distinguishing feature of this model for the HS analysis is the ability to account for the complex family structure of the HS rat. Variance components to correct for pedigree relationships were estimated using the EMMA package for the R statistical software 25 , and the test for association was conducted for each phenotype via a mixed model, adjusting for age, sex, body weight and batch. At each genotyped SNP on chromosomes 1-22 and X, the −log 10 (p-value) was computed. A genome-wide empiric significance threshold was obtained for each phenotype, corresponding to the 5% false discovery rate for that particular measure. A corresponding conservative overall threshold for the current study (P<3 × 10 −6 ; -log 10 P=5.5) was obtained by taking the largest −log 10 P value among these thresholds across all the bone density phenotypes. To further reduce type I error, the resample-based inclusion probability (RMIP) was computed for each QTL detected, and peaks with RMIP<0.3 (corresponding to an approximate specificity of 0.75) were excluded. All models were fitted using the statistical language R (R-Development-Core-Team 2004). 26 A 95% confidence interval for the position of each QTL detected was obtained as described previously 9, 27 , assuming a χ 2 1 distribution for lod to −log 10 (p-value) conversion. The sample had greater than 80% power to detect QTLs contributing 5% of the total variation in the BMD phenotypes measured, and approximately 70% power for QTLs of 3% effect at the conservative FDR and RMIP significance thresholds employed. Figure 1 shows linkage results obtained throughout the genome for the measurements of femur bone mineral content and density (A-D), femur neck density (E,F), and lumbar bone mineral content and density (G-I) in this study. Several QTLs reaching the genome-wide FDR and RMIP significance thresholds were observed in the HS rat sample, and are included in Table 1 . Candidate genes within the 95% confidence intervals (CI) for these QTLs are listed in Table 2 .
Results
Genome-wide significant association results for femur mineral content and density
On chromosome 10 at position 46.5 Mb, significant linkage was detected for femur BMC with a −logP value of 5.64 (p=2.3 × 10 −6 ; Figure 2A and Table 1 ). The CI for this QTL spanned less than half a megabase (Mb). On chromosome 9, a QTL was identified which was linked to several femur density phenotypes ( Figure 2B ). Within this region, a QTL for distal femur vBMD was observed, with a −logP value of 5.68 (p=2.1 × 10 −6 ). The same chromosome 9 region, spanning approximately 3.5 Mb, contained an additional QTL with substantial (but not genome-wide significant) evidence for linkage with distal femur trabecular vBMD (p=1.8 × 10 −5 ).
Genome-wide significant association results for femur neck bone mineral density
We observed two genome-wide significant QTLs for femoral neck density phenotypes, one each for femoral neck vBMD ( Figure 2B ) and for femoral neck cortical vBMD ( Figure 2C ). In the same 3.5 Mb region of chromosome 9 that our study identified for other femur density measures, a QTL for femoral neck vBMD was observed with a significant −logP value of 5.56 (p=2.7 × 10 −6 ). This coincided with the position of the distal femur and trabecular vBMD chromosome 9 QTLs above. With femur neck cortical vBMD, a QTL was observed at 182.1 Mb on chromosome 2, with a −logP value of 5.77 (p=1.7 × 10 −6 ; Figure 2C and Table 1 ).
Genome-wide significant association results for lumbar bone mineral content and density
An additional QTL at the proximal end of chromosome 13 was identified for lumbar 5 trabecular vBMD (p=9.7 × 10 −8 ; Figure 2D and Table 1 ). This QTL spanned 2.5 Mb, with a −logP value of 7.01.
Discussion
In previous work, we identified QTLs for bone density phenotypes using the F2 intercross approach in the rat model. 13 While quite powerful for QTL detection, this approach often results in QTL intervals encompassing a third to half of a chromosome containing several hundred genes. In this study, we exploited the unique genetic architecture in HS rat to detect and localize QTLs in a smaller region for several key BMD phenotypes at most common skeletal fracture sites. We utilized the pedigree structure and sequence data from the founder HS strains to identify genomic variants associated with these QTLs in the HS offspring and identified several chromosomal regions with strong evidence of association with bone mineral density. Importantly, most of these loci were localized to very small genomic regions (1-3 Mb) compared to the F2 design used previously for QTL mapping. This allows us to identify a much more focused list of potential candidate genes under each QTL peak for future functional studies, which are often prohibitive to conduct in large number of genes. In addition to several novel genes detected in the HS rat model (Aars2, Adar, Atpaf2,  Cdc5l, Chrnb2, Cntnap5b, Dap3, Dcst1/2, Kcnn3, Lrrc48, Mrpl14, Nup210l, Pbxip1, Pklr,  Scamp3, Shc1, Spats1, Supt3h, Tcte1, Tom1l2, Tmem63b, and Ube2q1, Zbtb7b) , we also identified skeletal candidate genes underlying these QTLs (Adam15, Capn11, Efna4, Il6,  Slc39a1, Srebf1, Thbs3, Tpm3, Rai1, Runx2 and Vegfa) that have been previously shown to have a role in skeletal development and homeostasis.
Among all the genes detected under the relatively narrow intervals in this study ( Table 2) , there are several genes in particular that have been previously reported to have important roles in bone homeostasis. Lack of Adam15 in mice is associated with increased osteoblast function and bone mass. 28 The calpains are a family of calcium-dependent thiol proteases involved in intracellular protein processing and have been shown to modulate cellular proliferation and differentiation in rodent osteoblast cells. 29 Also, these proteases are required for normal osteoclast and chrondrocyte function. 30, 31 Epha4 is necessary during bone growth and acts as a negative regulator of osteoclast activity. 32, 33 IL-6 receptor expression is increased during in vitro osteoblast differentiation. 34, 35 In addition, these receptors are involved in osteoclast formation and function. 36 Rai1 knockout mice are growth retarded and displays malformations in both the craniofacial and the axial skeleton. 37 Runx2 is a major transcription factor for chondrocyte and osteoblast differentiation. 38 Thbs3 influences geometric and biomechanical properties of bone. 39 Vegf is well known for its role in angiogenesis and osteogenesis [40] [41] [42] , and Tpm3 is expressed during osteoclast fusion and regulates osteoclast cytoskeletal morphology. 43 Association of a polymorphism in Srebf1 with osteonecrosis of the femoral head has been observed in Koreans. 44 Slc39a1 or Zip1 is expressed in osteoclasts and overexpression of the Zip1 induces osteogenic phenotype. 45, 46 In this study, we were able to replicate several chromosomal regions previously identified in our inbred F2 studies in HS rats. For example, we detected association with distal femur density in the HS rats on chromosome 9 (LOD 5.68), which overlapped the QTLs in our F344 X LEW and COP X DA F2 cross for femur neck structural phenotypes. 9, 11 Similarly, the femoral neck cortical vBMD QTL identified in HS rats on chromosome 2 (LOD 5.77) overlapped the QTL in F344 X LEW F2 cross for the same phenotype. 11 Importantly, using HS rats, we were able to fine-map these regions to 1-3 Mb resolution, enabling us to identify a much smaller number of potential candidate genes on chromosomes 2 and 9 ( Table 2 ). We also identified several novel chromosomal regions linked to bone density phenotypes in HS rats ( Table 2 ) not found in our F2 studies. On chromosome 9, a QTL was identified which was linked to several femur density phenotypes ( Figure 2B ) including distal femur total (both cortical and trabecular) and distal femur trabecular vBMD as well as femur neck vBMD. These results indicate that same gene/s may contribute not only trabecular and cortical compartments of bone mineral density but also influence density at different skeletal sites even within a given bone. Previous studies demonstrated site-specific genetic regulation of trabecular and cortical bone density in human and rodents. 7, 13, 47, 48 Thus, it is likely that sets of bone-specific genes might influence density across the different bones and the genetic architecture within the different combinations of these bone-specific genes might ultimately regulate the site-specific bone density.
The QTL region for femoral neck cortical vBMD on chromosome 2 in HS rat is syntenic to human 1q21.3-23.1, where linkage to spine BMD was detected previously. 49 The QTL region for distal femur and femoral neck vBMD on chromosome 9 in HS rat is homologous to the regions of mouse chromosome 17 (38.3-46.5 Mb) and human chromosome 6 (6p12.3-21.2). Linkage to mouse total body BMD and femur strength were reported before in this homologous region. 50, 51 In addition, the human homologous region was previously linked to femoral neck BMD and osteoarthritis and rheumatoid arthritis QTLs. [52] [53] [54] Similarly, femur BMC QTL detected on chromosome 10 in HS rat is homologous to the mouse chromosome 11 (59.4-60.6 Mb), which was previously linked to peak BMD. 55, 56 The human homologous region of 17p11.2 harbors gene that when overexpress lead to osteosarcoma. 57 Interestingly, deletion of the human syntenic region on chromosome 18q22 that corresponds to the QTL region on chromosome 13 for lumbar trabecular vBMD in HS rat was associated with multiple vertebral segmentation defects. 58 In this study, we demonstrated that HS rats are a powerful resource for fine mapping of QTLs for bone mineral density phenotypes. The complexity of the BMD phenotype in the rat is evident due to the inability to identify any specific sequence variants in the HS founder strains that fully accounted for BMD QTLs in our recent study. 23 This suggests that the genetic variation underlying the BMD QTL is due to multiple variants inherited from different founders and may also reflect interactions among the variants. Given the results of the analysis of the founder animal sequencing data, we have now focused on the identification of additional BMD QTLs in the HS rat model using conservative genomewide significance thresholds. For the bone density QTLs detected, this approach had the great benefit of allowing us to delineate a much smaller chromosomal interval and thus narrower list of potential candidate than the F2 approach. We anticipate that sequencing studies in the HS offspring in these narrowed regions will be necessary to augment the founder strain sequence data currently available as part of the HS collaboration. 23 The availability of these data will allow the dissection of the complex genetic interactions among these sequence variants which likely underlies the BMD phenotypes in the tested animals. 
Tmem63b
Transmembrane protein 63B
Tmem151b Transmembrane protein 151B
Tctel T-complex-associated testis expressed 1
Cdc5l
Cell division cycle 5-like
Phenotypes Chromosome Interval (Mb) Gene symbol
Gene name
Human synteny
Supt3h
Suppressor of Ty3 homolog (S. cerevisiae)
Spats1
Spermatogenesis associated serine-rich 1
Hsp90ab1
Heat shock protein 90 alpha (cytosolic) class B member 1
Femur BMC (g) 10 46.3 -46.8
Srebf1
Sterol regulatory element-binding protein 1
17p11.2
Tom1l2 TOM1-like protein 2
Lrrc48
Leucine-rich repeat-containing protein 48
Atpaf2 ATP synthase mitochondrial F1 complex assembly factor 2
Rail
Retinoic acid induced 1
Lumbar 5 trabecular vBMD (mg/cm 3 ) 13 0 -2.5
Cntnap5b
Contactin-associated protein like 5-2 2q14.3
SNORA17
Small nucleolar RNA SNORA17 18q22.1
7SK
7SK RNA
